Verapamil Reverts Acute Renal Functional Impairment Induced by Angiotensin II Converting Enzyme Inhibitors

References

• Hollenberg N.K., Raij L. Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy. Arch. Intern. Med. 1993; 153: 2426–2435
   Google Scholar
• ter Wee P.M., DeMicheli A.G., Epstein M. Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease. Arch. Intern. Med. 1994; 154: 1185–1202
   Google Scholar
• Lewis E.J., Hunsicker L.G., Bain R.P., Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: the collaborative study Group. N. Engl. J. Med. 1993; 329: 1456–1462
   Google Scholar
• Ravid M., Lang R., Rachmani R., Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in noninsulin-dependent mellitus. A 7-year follow-up study. Arch. Intern. Med. 1996; 156: 286–289
   Google Scholar
• Ruggenenti P., Perna A., Gherardi G., Garini G., Zocalli C., Salvadori M., Scolari F., Schena F.P., Remuzzi G. Renoprotective properties of ACE-inhibition in nondiabetic nephropathies with nonnephrotic proteinuria. The Lancet 1999; 354: 359–364
   Google Scholar
• Toto R., Mitchell H., Lee H., Milan C., Pettinger W. Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis. Ann. Intern. Med. 1991; 115: 513–519
   Google Scholar
• Gotloib L., Jaichenko S., Fudin R., Shostok A. Severe reduction of renal function in hypertensive and/or diabetics induced by angiotensin-converting enzyme inhibitors. Nephron 1995; 71: 230–231
   Google Scholar
• Toto R.D. Renal insufficiency due to angiotensin-converting enzyme inhibitors. Miner Electrolyte Metab. 1994; 20: 193–200
   Google Scholar
• Bakris G.L., Weir M.R. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine. Is this a cause for concern?. Arch. Intern. Med. 2000; 160: 685–693
   Google Scholar
• Bakris G.L., Willians B. Angiotensin converting enzyme inhibitors and calcium antagonist alone or combined: does the progression of diabetic renal disease differ?. J. Hipertens 1995; 13(suppl 2)S95–S101
   Google Scholar
• Griffin K.A., Picken M.M., Bakris G., Bidani A. Class differences in the effects of calcium blockers in the rat remnant kidney model. Kidney Int. 1999; 55: 1849–1860
   Google Scholar
• Abbott K.C., Bakris G. Renal effects of antihypertensive medications: an overview. J. Clin. Pharmacol. 1993; 33: 392–399
   Google Scholar
• Shultz P.J., Raij L. Inhibition of human mesangial cell proliferation by calcium channel blockers. Hypertension 1990; 15(suppl I)176–180
   Google Scholar
• Epstein M. Calcium antagonists and renal protection. Arch. Intern. Med. 1992; 152: 1573–1584
   Google Scholar
• Hoelscher D., Bakris G. Antihypertensive therapy and progression of diabetic renal disease. J. Cardiovas. Pharmacol. 1994; 23(suppl 1)S34–S38
   Google Scholar
• Münter K., Hergenroder S., Jochims K., Kirchengast M. Individual and combined effects of verapamil or trandolapril on attenuating hypertensive glomerulopatic changes in the stroke prone rats. J. Am. Soc. Nephrol. 1996; 7: 681–686
   Google Scholar
• Flores O., Arévalo M., Gallego B., Hidalgo F., Vidal S., López-Novoa J.M. Beneficial effect of the long-term treatment with the combination of an ACE Inhibitor and a calcium channel blocker on renal injury in rats with 5/6 nephrectomy. Exp. Nephrol. 1998; 6: 39–49
   Google Scholar
• Bitar R., Martín B., López-Novoa J.M., Macías-Núñez J.F. Reduction of renal function by angiotensin-converting enzyme inhibitors. Effect of verapamil. Nephron 1997; 75: 486–487
   Google Scholar
• Bosnes R.W., Tausski H.A. The colorimetric determination of creatinine of the Jaffé reaction. J. Biol. Chem. 1945; 158: 581–583
   Google Scholar
• Garg R., Yusuf S. for the collaborative group on ACE inhibitor trials: overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273: 1450–1456
   Google Scholar
• Echemann M., Zannad F., Briancon S., Juillière Y., Mertés P.M., Virion J.M., Villemot J.P. Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular dysfunction: the EPICAL study. Am. Heart J. 2000; 139: 624–631
   Google Scholar
• Zanchi A., Brunner H., Waeber B., Bumier M. Renal hemodynamic and protective effects of calcium antagonists in hypertension. J. Hypertens. 1995; 13: 1363–1375
   Google Scholar
• Meyer T.W., Anderson S., Rennke H.G., Brenner B.M. Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int. 1987; 31: 752–729
   Google Scholar
• Fenoy F.J., Scicli G., Carretero O., Roman R.J. Effect of angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril. Hypertension 1991; 17: 1038–1044
   Google Scholar
• Regoli D., Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 1980; 32: 1–46
   Google Scholar
• Bascands J.L., Pecher C., Rouaud S., Emond C., Tack J.L., Bastie M.J., Burch R., Regoli D., Girolami J.P. Evidence for existence of two distinct bradykinin receptors on rat mesangial cells. Am. J. Physiol. 1993; 264: F548–F556
   Google Scholar
• Edmond C., Bascands J.L., Cabos-Boutot G., Pecher C., Girolami J.P. Effects of change in sodium and water intake on on glomerular B2-kinin site. Am. J. Physiol. 1989; 257: F353–F358
   Google Scholar
• Mombouli J.V., Vanhoutte J.M. Kinins and endothelial control of vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol. 1995; 35: 679–705
   Google Scholar
• Bascands J.L., Pecher C., Bompart G., Rakotoarivony J., Tack J.L., Girolami J.P. Bradykinin-induced in vitro contraction of rat mesangial cells via a B2 receptor type. Am. J. Physiol. 1994; 267: F871–F878
   Google Scholar
• Rodríguez-Barbero A., Martínez-Salgado C., López-Novoa J.M., Macías-Núñez J.F. Perindopril stimulates cultured mesangial cells activation via bradykinin accumulation. Cell Physiol. Biochem. 1997; 7: 69–80
   Google Scholar
• Dixon B.S., Breckon R., Fortune J., Vavrek R.J., Stewart J.M., Marzec-Calvert R., Linas S.L. Effects of kinins on cultured arterial smooth muscle. Am. J. Physiol. 1990; 258: C299–C308
   Google Scholar
• Dworkin L.D., Beinstein J.A., Parker M., Tolbert E., Feiner D.H. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanism. Kidney Int. 1993; 43: 808–814
   Google Scholar
• Macías-Núñez J.F., García Iglesias C., Santos J.C., Sanz E., López-Novoa J.M. Influence of plasma renin content, intrarenal AII, captopril and calcium channel blockers on the vasoconstriction and renin release promoted by adenosine in the kidney. J. Lab. Clin. Med. 1985; 106: 562–567
   Google Scholar
• Olivera A., Tomás M., López-Novoa J.M. Effect of A1 and A2 agonists and antagonists on cAMP and Ca2+ in cultured rat mesangial cells. Am. J. Physiol. 1992; 262: C840–C845
   Google Scholar
• Montero A., González-Sarmiento R., Rodríguez-López A.M., López-Novoa J.M. Effect of verapamil on endothelin-1 induced proliferation in cultured rat mesangial cells. Cell Physiol. Biochem. 1995; 5: 155–66
   Google Scholar
• García-Cosmes P., Montero A., López-Novoa J.M., Macías-Núñez J.F. Is renal protection with calcium antagonists possible?. Drugs 1992; 44: 99–102
   Google Scholar
• Tschudi M.R., Noll G., Wenzel R.R., Lüscher T.F. Calcium antagonists and endothelial function interaction with nitric oxide and endothelin. J. Cardiovasc. Pharmacol. 1997; 30(suppl 3)S9–S17
   Google Scholar
• Dale J., Landrk K.H., Myhre E. The effect of nifedipine, a calcium antagonist, on platelet function. Am. Heart J. 1983; 105: 103–105
   Google Scholar
• Pukerson M., Joist J.H., Greenberg J.M, Kay D., Hoffstein P.E., Klahr S. Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in rats. Tromb. Res. 1982; 26: 227–240
   Google Scholar
• Harris J.P.D.C.H., Chan L., Schrier R.W. Remnant kidney hypermetabolism and progression of chronic renal failure. Am. J. Physiol. 1988; 254: F267–F276
   Google Scholar